In the absence of PVT1-miR-16-5p/VEGFA/VEGFR1/AKT, signaling pathway is inactive, thereby inhibiting the progression of CRC (Wu et al., 2020a). The gene discussed is FLT1; the disease is colorectal carcinoma.